Published in
Nature Research, Nature Medicine, 5(27), p. 793-801, 2021
DOI: 10.1038/s41591-021-01317-6
Links
Tools
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer
Journal article published in 2021 by
Thomas Powles 
,
Danielle Carroll,
Simon Chowdhury,
Gwenaelle Gravis,
Florence Joly,
Joan Carles,
Aude Fléchon,
Pablo Maroto,
Daniel Petrylak,
Frédéric Rolland ,
Natalie Cook ,
Arjun V. Balar,
Srikala S. Sridhar,
Matthew D. Galsky,
Petros Grivas
and other authors.
,
Danielle Carroll,
Simon Chowdhury,
Gwenaelle Gravis,
Florence Joly,
Joan Carles,
Aude Fléchon,
Pablo Maroto,
Daniel Petrylak,
Frédéric Rolland ,
Natalie Cook ,
Arjun V. Balar,
Srikala S. Sridhar,
Matthew D. Galsky,
Petros Grivas
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 